Gilead Sciences, Inc. (GILD) vs Novo Nordisk A/S (NVO)
A side-by-side comparison of Gilead Sciences, Inc. and Novo Nordisk A/S across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.
GILD
Gilead Sciences, Inc.
$146.30HealthcareDelayed quote: Sep 15, 2026, 4:00 PM EDT
NVO
Novo Nordisk A/S
$42.53HealthcareDelayed quote: Sep 15, 2026, 4:00 PM EDT
Total return — GILD vs NVO
growth of $100 · dividends reinvested · last 10yGILD +159.4% (+10.0%/yr)NVO +135.8% (+9.0%/yr)GILD compounded faster over this window
GILD NVO
GILD vs NVO: by the numbers
- •NVO is the larger company ($188.86B vs $181.64B market cap).
- •NVO is profitable (35.33% net margin) while GILD runs a net loss (-10.64%).
- •NVO grew revenue faster over the past five years (19.76% vs 2.72% CAGR).
- •NVO pays the higher dividend yield (4.17% vs 2.24%).
Metrics side by side
Valuation
| Metric | GILD | NVO |
|---|---|---|
| P/E ratio | N/A | 10.48 |
| P/S ratio | 5.96 | 3.70 |
| P/B ratio | 15.36 | 5.60 |
| EV / EBITDA | N/A | 7.76 |
| FCF yield | 7.14% | 3.94% |
Profitability
| Metric | GILD | NVO |
|---|---|---|
| Gross margin | 79.59% | 80.64% |
| Operating margin | 39.74% | 43.10% |
| Net margin | -10.64% | 35.33% |
| ROE | -27.39% | 53.50% |
| ROIC | -3.66% | 30.21% |
Dividends
| Metric | GILD | NVO |
|---|---|---|
| Dividend yield | 2.24% | 4.17% |
| Payout ratio | N/A | 44.27% |
Growth (annualized)
| Metric | GILD | NVO |
|---|---|---|
| Revenue CAGR (5Y) | 2.72% | 19.76% |
| EPS CAGR (5Y) | 133.83% | 19.59% |
| FCF CAGR (5Y) | 9.27% | -1.45% |
| Total return CAGR (5Y) | 19.41% | -0.65% |
Frequently asked
- Which has grown faster, GILD or NVO?
- Over the past five years, NVO grew revenue faster — GILD at a 2.72% CAGR versus NVO at 19.76%.
- Does GILD or NVO pay a bigger dividend?
- GILD yields 2.24% and NVO yields 4.17% based on trailing dividends and the latest price.
- Is GILD or NVO more profitable?
- NVO runs the higher net margin — GILD at -10.64% versus NVO at 35.33%.
- How have GILD and NVO total returns compared?
- Over the past 10 years, GILD delivered 10.13% and NVO delivered 9.46% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Novo Nordisk A/S P/E ratioGilead Sciences dividend yieldNovo Nordisk A/S dividend yieldGilead Sciences ROENovo Nordisk A/S ROEGilead Sciences operating marginNovo Nordisk A/S operating marginGilead Sciences revenue growthNovo Nordisk A/S revenue growthGilead Sciences free cash flowNovo Nordisk A/S free cash flow
Gilead Sciences & Novo Nordisk A/S appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.